V
Victor W. Henderson
Researcher at Stanford University
Publications - 307
Citations - 20298
Victor W. Henderson is an academic researcher from Stanford University. The author has contributed to research in topics: Dementia & Population. The author has an hindex of 66, co-authored 278 publications receiving 18185 citations. Previous affiliations of Victor W. Henderson include University of Melbourne & Aarhus University Hospital.
Papers
More filters
Journal ArticleDOI
Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
Stephen R. Rapp,Mark A. Espeland,Sally A. Shumaker,Victor W. Henderson,Robert L. Brunner,JoAnn E. Manson,Margery Gass,Marcia L. Stefanick,Dorothy S. Lane,Jennifer Hays,Karen C. Johnson,Laura H. Coker,Maggie Dailey,Deborah J. Bowen +13 more
TL;DR: Among postmenopausal women aged 65 years or older, estrogen plus progestin did not improve cognitive function when compared with placebo, and timing of prior hormone therapy initiation with respect to the final menstrual period did not affect the results.
Journal ArticleDOI
Estrogen Deficiency and Risk of Alzheimer's Disease in Women
TL;DR: It is suggested that the increased incidence of Alzheimer's disease in older women may be due to estrogen deficiency and that estrogen replacement therapy may be useful for preventing or delaying the onset of this dementia.
Journal ArticleDOI
Postmenopausal Hormone Therapy: An Endocrine Society Scientific Statement
Richard J. Santen,D. Craig Allred,Stacy P. Ardoin,David F. Archer,Norman F. Boyd,Glenn D. Braunstein,Henry G. Burger,Graham A. Colditz,Susan R. Davis,Marco Gambacciani,Barbara A. Gower,Victor W. Henderson,Wael N. Jarjour,Richard H. Karas,Michael Kleerekoper,Roger A. Lobo,JoAnn E. Manson,Jo Marsden,Kathryn A. Martin,Lisa W. Martin,JoAnn V. Pinkerton,David R. Rubinow,Helena J. Teede,Diane Thiboutot,Wulf H. Utian +24 more
TL;DR: A scholarly review of the published literature on menopausal hormonal therapy (MHT), make scientifically valid assessments of the available data, and grade the level of evidence available for each clinically important endpoint to arrive at major conclusions.
Journal ArticleDOI
Estrogen replacement therapy in older women. Comparisons between Alzheimer's disease cases and nondemented control subjects.
TL;DR: Findings are consistent with contentions that postmenopausal estrogen replacement therapy may be associated with a decreased risk of AD and that estrogen replacement may improve cognitive performance of women with this illness.
Journal ArticleDOI
Sex modifies the APOE-related risk of developing Alzheimer disease.
Andre Altmann,Lu Tian,Victor W. Henderson,Michael D. Greicius,Alzheimer's Disease Neuroimaging Initiative Investigators +4 more
TL;DR: The APOE4‐by‐sex interaction in conversion risk (from healthy aging to mild cognitive impairment (MCI)/AD or from MCI to AD) and cerebrospinal fluid (CSF) biomarker levels is examined.